查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1914152

磁粒子成像設備市場按產品類型、應用、通路和最終用戶分類－2026-2032年全球預測

Magnetic Particle Imaging Device Market by Product Type, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年磁粒子成像設備市值為1.6526億美元，預計2026年將成長至1.9049億美元，複合年成長率為16.48%，到2032年將達到4.8092億美元。

關鍵市場統計數據
基準年 2025 1.6526億美元
預計年份：2026年 1.9049億美元
預測年份 2032 4.8092億美元
複合年成長率 (%) 16.48%

簡要介紹磁粒子成像（MPI）的技術特性、潛在應用和不斷發展的設備生態系統

磁粒子成像（MPI）是一種快速發展的成像技術，它利用超順磁性氧化鐵奈米粒子的特異性磁響應，無需電離輻射即可產生高靈敏度、高對比度的影像。與依賴衰減或質子弛豫的現有臨床成像技術不同，MPI 直接檢測示蹤劑的磁化強度，從而提供針對特定奈米粒子造影劑的即時訊號。這項技術特性為廣泛的潛在臨床和研究應用奠定了基礎，涵蓋血管成像到臨床前腫瘤學研究中的靶向示踪追蹤等領域。

儀器研發、示蹤劑創新和合作研究路徑的新轉折點正在重塑磁粒子成像技術，使其從研究走向臨床實踐。

隨著技術的成熟、臨床需求的成長以及監管機構的積極參與，磁粒子成像（MPI）領域正經歷著一場變革性的轉變。 MPI最初僅限於一些專業的臨床前研究團隊，如今已吸引了許多設備創新者的廣泛關注，他們致力於開發針對特異性器官的臨床系統以及全身成像系統。這項轉變的驅動力主要來自示蹤劑化學技術的進步，這些進步提高了訊號保真度和生物相容性；以及演算法的進步，這些進步加速了影像重建並減少了偽影。

評估近期美國關稅調整對成像設備開發商的採購、製造策略和供應鏈韌性的影響

美國政策環境的調整導致進口先進診斷影像設備所需的專用零件和材料受到關稅影響。這些變化使得從國際市場採購磁場發生硬體、電力電子元件和精密運動部件的企業面臨更複雜的成本環境。因此，設備開發商及其供應商正在重新調整籌資策略，以降低關稅波動帶來的風險，同時保持供應鏈的穩健性。

詳細的細分分析重點闡述了產品類型、應用、分銷管道和終端用戶趨勢對設備策略和採用率的影響。

了解細分市場的細微差別有助於我們了解磁粒子成像技術拓展的多種途徑，以及針對不同使用者需求的價值累積領域。根據產品類型，市場可分為臨床系統和臨床前系統。臨床產品可進一步細分為針對特定器官的高解析度成像系統（旨在局部應用）和全身成像系統（旨在拓展適應症並促進臨床應用）。臨床前平台則分為連結轉化研究的大型動物系統和針對高通量實驗室研究最佳化的小型動物系統，兩者分別滿足不同的實驗和檢驗需求。

區域趨勢和跨國合作將影響MPI所採取的監管路徑、臨床檢驗地點和區域生產策略。

地理動態在磁粒子成像技術的應用路徑和商業策略中發揮著至關重要的作用，因為區域生態系統塑造著監管路徑、臨床合作和供應鏈結構。在美洲，臨床研究中心和先進的轉化醫學中心推動早期臨床可行性研究，加上設備創新者和學術醫療中心的聚集，加速了多學科檢驗。這種環境支援設備的迭代改進，並促進了產業界與臨床研究人員之間的夥伴關係。

繪製競爭格局圖：視覺化硬體創新者、追蹤專家和策略夥伴如何合作推動MPI商業化

磁粒子成像 (MPI) 產業格局涵蓋了成熟的成像公司、專注於 MPI 硬體或示蹤劑化學的專業新創公司，以及能夠實現規模化生產的契約製造製造商。成熟的影像供應商提供Start-Ups專業知識、臨床工作流程整合能力和成熟的商業管道，並可透過捆綁式解決方案和現有客戶關係加速臨床應用。同時，Start-Ups往往是線圈設計、低噪音電子元件和奈米粒子工程領域快速創新的源泉，它們經常與學術團隊合作，在受控的臨床前環境中檢驗新方法。

開發商和相關人員可以採取哪些切實可行的策略步驟來加速MPI臨床檢驗、保障供應鏈並最佳化上市流程？

產業領導者可以透過優先進行一系列合作行動，使技術開發與臨床需求和商業性現實相契合，從而加速磁粒子成像技術的臨床應用和廣泛推廣。首先，投資於示蹤劑和設備的共同開發項目，以同時最佳化奈米粒子配方和掃描器參數。這將縮短迭代周期，並增強臨床應用的合理性。其次，制定臨床檢驗路徑，從器官特異性可行性研究入手，逐步推進至更廣泛的臨床應用，進而在控制證據風險的同時拓展適應症。這種分階段的方法將有助於更清楚地進行醫保報銷談判，並實現對臨床效用的精準論證。

採用綜合性的混合研究途徑，結合相關人員訪談、技術檢驗和系統性的二手資料研究，確保研究結果的可靠性。

本報告的調查方法結合了定性研究和來自技術和監管文獻的定量三角驗證。定性研究包括對設備工程師、示踪劑科學家、臨床研究人員、醫院和研究機構的採購人員以及分銷合作夥伴進行結構化訪談，以收集有關技術要求、實施障礙和服務期望的第一手資訊。這些訪談輔以技術檢驗，該工作包括審查與造影劑和診斷影像設備相關的同行評審文章、臨床前試驗通訊協定和監管指導文件。

關於如何協調技術、監管和商業性實施，從而將磁粒子成像的潛力轉化為持續的臨床和研究影響的策略性結論

磁粒子成像技術正處於一個關鍵的轉折點，其成熟的技術優勢、日益成長的臨床應用需求以及與規模化生產、監管合規和供應鏈最佳化相關的實際挑戰交織在一起。該技術固有的示蹤訊號特異性和即時定量成像潛力，為標靶臨床應用和轉化研究提供了明確的價值提案，能夠連接實驗室研究和患者研究。然而，其應用的速度和模式將取決於開發人員如何有效地解決與現有工作流程的整合、針對特定適應症的證據產生以及醫療系統和研究客戶的營運需求等問題。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：磁粒子成像設備市場（依產品類型分類）

  • 臨床應用
    • 器官特異性
    • 全身
  • 臨床前
    • 大型動物
    • 小動物

第9章 磁粒子成像設備市場（依應用領域分類）

  • 臨床診斷
    • 心血管影像
    • 神經影像學
  • 臨床前研究
    • 心血管調查
    • 腫瘤學
      • 轉移檢測
      • 腫瘤影像

第10章 磁粒子成像設備市場（依通路分類）

  • 直銷
    • 現場銷售
    • 線上銷售
  • 經銷商
    • OEM合作夥伴
    • 第三者

第11章：依最終用戶分類的磁粒子成像設備市場

  • 醫院
    • 私人診所
    • 公立醫院
  • 研究所
    • 學術機構
    • 政府

第12章：磁粒子成像設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：磁粒子成像設備市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國磁力粒子成像設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國磁力粒子成像設備市場

第16章 中國磁粒子影像設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aspect Imaging Ltd.
  • Bayer AG
  • BMG LABTECH GmbH
  • Bruker BioSpin GmbH
  • Danfoss A/S
  • I'rom Pharmaceutical Co., Ltd.
  • Koninklijke Philips NV
  • Magnetic Insight, Inc.
  • MILabs BV
  • Mitsubishi Electric
  • Siemens Healthineers AG
Product Code: MRR-AE420CB13B4F

The Magnetic Particle Imaging Device Market was valued at USD 165.26 million in 2025 and is projected to grow to USD 190.49 million in 2026, with a CAGR of 16.48%, reaching USD 480.92 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 165.26 million
Estimated Year [2026] USD 190.49 million
Forecast Year [2032] USD 480.92 million
CAGR (%) 16.48%

A concise introduction to magnetic particle imaging outlining its technical distinctiveness, translational promise, and evolving device ecosystem

Magnetic Particle Imaging (MPI) represents a rapidly maturing imaging modality that leverages the unique magnetic response of superparamagnetic iron oxide nanoparticles to generate high-sensitivity, high-contrast images without ionizing radiation. Unlike established clinical modalities that rely on attenuation or proton relaxation, MPI directly detects tracer magnetization, delivering a real-time signal that is inherently specific to the administered nanoparticle contrast agent. This technical distinction underpins a range of potential clinical and research applications, from vascular imaging to targeted tracer tracking in preclinical oncology studies.

Early adopters in preclinical laboratories have demonstrated MPI's ability to visualize tracer dynamics with temporal resolution suited to perfusion and functional studies, while organ-specific device designs and whole-body system concepts are progressing through prototype and regulatory pathways. As a result, MPI is transitioning from a primarily investigational technique to a platform with emerging translational trajectories. The device ecosystem spans benchtop preclinical scanners optimized for small and large animal models, organ-focused clinical prototypes engineered for high-resolution target imaging, and evolving whole-body concepts intended to broaden clinical utility.

Technical innovation continues to be driven by advances in nanoparticle engineering, scanner architecture, and reconstruction algorithms. These developments have reduced some historical limitations around spatial resolution and sensitivity, while enabling lower tracer doses and faster acquisition times. At the same time, integration with complementary imaging modalities and compatible workflows is becoming a priority for clinical translation, prompting cross-disciplinary collaborations among imaging physicists, materials scientists, device engineers, and clinical investigators. Consequently, decision makers must weigh technical maturity, regulatory strategy, and operational integration when considering MPI adoption.

Emerging inflection in device development, tracer innovation, and collaborative pathways that are reshaping magnetic particle imaging from research to clinical practice

The landscape for magnetic particle imaging is undergoing transformative shifts as technical maturation aligns with growing clinical interest and regulatory engagement. Initially concentrated within specialized preclinical research groups, MPI is now attracting broader attention from device innovators pursuing both organ-specific clinical systems and whole-body form factors. This transition is being catalyzed by improvements in tracer chemistry, which have enhanced signal fidelity and biocompatibility, and by algorithmic advances that accelerate image reconstruction while reducing artifacts.

In parallel, strategic partnerships across academia, early-stage industry players, and larger medical device organizations are reshaping development pathways. These collaborations facilitate rapid iteration of hardware designs, validation studies across diverse biological models, and coordinated submissions for clinical feasibility trials. Importantly, the role of complementary modalities such as MRI and ultrasound is becoming more prominent, with hybrid workflows and data fusion approaches enabling richer diagnostic interpretation and clinical decision support. The shift toward integrated imaging strategies reinforces the necessity of interoperability standards, reproducible protocols, and robust tracer supply chains.

From a deployment perspective, the device footprint and cost profile are evolving alongside user requirements. Organ-specific devices aim to deliver high-resolution imaging with compact installations suitable for specialty centers, whereas whole-body ambitions seek to broaden clinical indications but face more stringent infrastructural and reimbursement considerations. As a result, stakeholders must adopt flexible development and commercialization strategies that accommodate phased clinical evidence generation, differentiated product tiers, and targeted market entry points. Taken together, these dynamics signal an inflection point in which MPI moves from niche research tool toward a clinically relevant imaging option, contingent on coordinated progress across technology, regulation, and clinical validation.

Assessing how recent tariff adjustments in the United States are altering procurement, manufacturing strategy, and supply chain resilience for imaging device developers

The policy environment in the United States has introduced tariff adjustments that affect the importation of specialized components and materials integral to advanced imaging device manufacturing. These changes create a more complex cost environment for firms that source field-generating hardware, power electronics, and precision motion components internationally. Consequently, device developers and their suppliers are recalibrating procurement strategies to mitigate exposure to variable duties while preserving supply chain resilience.

In response, multiple manufacturers have begun to diversify their supplier base, prioritize onshoring of critical subsystems where economically viable, and renegotiate long-term agreements with partners capable of absorbing some tariff volatility. At the same time, the tariffs have incentivized vertical integration in specific segments of the value chain, particularly for companies seeking to secure access to high-quality drive coils, gradient amplifiers, and tracer formulation materials. These strategic moves are coupled with cost modeling that factors in potential duty fluctuations, logistics lead times, and inventory positioning to sustain development timelines.

Beyond procurement, regulatory and clinical trial planning is being adapted to account for potential delays in component availability and increased unit costs for prototype and clinical systems. Organizations pursuing accelerated translation are assessing manufacturing strategies that balance domestic production, contract manufacturing in tariff-favorable jurisdictions, and strategic inventory buffers. For purchasers and health systems, procurement decisions now weigh not only device capabilities but also demonstrated supply continuity and long-term serviceability. Ultimately, while tariffs introduce short- to medium-term headwinds to cost structures, they are also prompting strategic supply-chain redesigns that can yield greater control over quality and delivery reliability across the device lifecycle.

In-depth segmentation analysis revealing how product type, application, distribution channels, and end-user dynamics influence device strategy and adoption

A nuanced understanding of segmentation clarifies the diverse pathways through which magnetic particle imaging can scale and where value accrues across different user needs. Based on product type, the market bifurcates into clinical and preclinical systems. Clinical offerings can be further differentiated by organ-specific designs that target localized, high-resolution applications and by whole-body systems that aim to broaden indication sets and institutional adoption. Preclinical platforms break down into large animal systems that bridge translational studies and small animal systems optimized for high-throughput laboratory research, each addressing distinct experimental and validation requirements.

Application-based segmentation highlights how clinical diagnosis and preclinical research drive device and tracer requirements differently. Clinical diagnostic use cases include cardiovascular imaging that demands rapid temporal resolution and vascular specificity, as well as neurological imaging where localized tracer delivery and sensitivity to small-volume distribution patterns are paramount. Preclinical research applications emphasize cardiovascular research workflows that probe perfusion and device-tissue interactions and oncology studies where tracer behavior is monitored for tumor imaging and metastasis detection. Within oncology, capabilities that facilitate metastasis detection and high-contrast tumor imaging are especially valued for translational research and targeted therapeutic development.

Distribution channel segmentation informs go-to-market and support models, with direct sales channels encompassing field-based engagement and digital sales pathways tailored to complex capital equipment. Field sales enable onsite demonstration, clinical workflow integration assistance, and relationship-driven procurement, while online sales support streamlined procurement for standardized or lower-complexity platforms. Distributor networks include OEM partnerships that embed MPI capabilities within broader imaging suites and third-party distributors who extend geographic reach and localized service capabilities. End-user segmentation delineates hospitals and research institutes as primary customers. Hospitals require device designs compatible with private clinic workflows and public hospital procurement and service standards, whereas research institutes include academic and government laboratories that prioritize reproducibility, modularity, and research-focused support packages.

Taken together, these segmentation perspectives shape product design, regulatory planning, and commercialization strategies. They also influence the types of evidence and service models purchasers will expect, from longitudinal clinical studies for organ-specific clinical devices to flexible research agreements and reagent supply models for preclinical systems. Therefore, a coherent product and market approach must align technical specifications, distribution choices, and support offerings with the distinct expectations of each segment.

Regional dynamics and cross-border collaboration that determine regulatory routes, clinical validation hubs, and localized manufacturing strategies for MPI adoption

Geographic dynamics play a pivotal role in the adoption trajectory and commercial strategy for magnetic particle imaging technologies, with regional ecosystems shaping regulatory pathways, clinical engagement, and supply chain configurations. In the Americas, clinical research hubs and advanced translational centers drive early clinical feasibility studies, complemented by a concentration of device innovators and academic medical centers that can accelerate multidisciplinary validation. This environment supports iterative device refinement and fosters partnerships that bridge industry and clinical investigators.

In Europe, Middle East & Africa, regulatory harmonization initiatives and strong translational research networks contribute to structured clinical evaluation pathways. Regional centers of excellence, often affiliated with major universities and public research institutes, are pivotal for demonstrating modality-specific advantages in targeted indications. Market access strategies in these jurisdictions emphasize robust clinical evidence and alignment with regional reimbursement mechanisms. In the Asia-Pacific region, rapid investments in research infrastructure and a growing appetite for advanced imaging technologies are driving significant interest in both preclinical and clinical MPI applications. Local manufacturers and research consortia are active in developing tracer chemistry, scanner designs adapted to regional clinical workflows, and localized service ecosystems to support deployment at scale.

Across all regions, cross-border collaboration and multi-center studies are increasingly common, enabling comparative validation and standardization. Nonetheless, regional differences in regulatory expectations, procurement practices, and clinical priorities necessitate tailored engagement plans. For device developers and suppliers, regional strategy should account for the relative strength of research communities, pathways for regulatory clearance or approval, and the maturity of domestic manufacturing and service capabilities to ensure sustainable market entry and expansion.

Mapping the competitive ecosystem to highlight how hardware innovators, tracer specialists, and strategic partners combine to drive MPI commercialization

The company landscape for magnetic particle imaging encompasses established imaging firms, specialized startups focused exclusively on MPI hardware or tracer chemistry, and contract manufacturers that enable scalable production. Established imaging suppliers contribute systems engineering expertise, clinical workflow integration capabilities, and established commercial channels that can accelerate clinical translation through bundled solutions and existing customer relationships. In contrast, startups are frequently the source of rapid innovation in coil design, low-noise electronics, and nanoparticle engineering, and they often collaborate with academic groups to validate novel approaches in controlled preclinical settings.

Strategic partnerships are a recurring theme among industry participants, enabling complementary capabilities to be combined into more compelling propositions. For example, hardware-focused companies commonly partner with tracer developers to optimize signal characteristics and with algorithm providers to enhance reconstruction and quantitative analysis. Contract manufacturers and service partners play a critical role in scaling production, ensuring traceability and quality control for contrast agents, and supporting aftermarket service contracts that are essential for clinical adopters. Investors and strategic acquirers are monitoring proof-of-concept clinical studies and regulatory milestones as signals for downstream consolidation opportunities.

Competitive dynamics are shaped by technical differentiation, intellectual property around nanoparticle formulations and scanner components, and the ability to demonstrate reproducible clinical or preclinical results. As clinical evidence accumulates, collaboration opportunities with larger medical device companies or diagnostic imaging networks are likely to increase, presenting pathways for accelerated commercialization and broader market access. For industry observers and potential partners, evaluating the capability mix-ranging from hardware design and manufacturing to tracer chemistry and clinical trial execution-is central to forming effective alliances and investment decisions.

Actionable strategic steps for developers and stakeholders to accelerate clinical validation, secure supply chains, and optimize go-to-market execution for MPI

Industry leaders can accelerate translation and adoption of magnetic particle imaging by prioritizing a set of coordinated actions that align technical development with clinical needs and commercial realities. First, invest in tracer-device co-development programs to ensure that nanoparticle formulations and scanner parameters are optimized in tandem; this reduces iteration cycles and strengthens the clinical case for adoption. Second, structure clinical validation pathways that begin with organ-specific feasibility studies and progress to broader clinical implementations, thereby managing evidence risk while expanding potential indications. These phased approaches support clearer reimbursement dialogues and enable targeted demonstration of clinical utility.

Third, build resilient supply chains that combine domestic production capabilities for critical subsystems with diversified international partnerships for components where onshoring is not feasible. This approach mitigates exposure to tariff volatility and logistics disruptions while preserving cost competitiveness. Fourth, create flexible distribution and service models that reflect segmentation realities: field-based clinical engagement for organ-specific devices, and scalable service architectures for preclinical systems used across academic and government laboratories. Finally, engage early with regulatory bodies and reimbursement stakeholders to clarify evidence requirements and to design studies that address decision-maker priorities. By implementing these actions, organizations can reduce commercialization friction, enhance stakeholder confidence, and position their offerings for accelerated adoption in both research and clinical settings.

Comprehensive mixed-method research approach combining stakeholder interviews, technical validation, and systematic secondary analysis to ensure robust insights

The research methodology underpinning this report integrates primary qualitative engagement with quantitative triangulation from technical literature and regulatory documentation. Primary research comprised structured interviews with device engineers, tracer scientists, clinical investigators, procurement leaders at hospitals and research institutes, and distribution partners to capture first-hand perspectives on technical requirements, adoption barriers, and service expectations. These interviews were complemented by technical validation exercises that reviewed peer-reviewed publications, preclinical study protocols, and regulatory guidance documents relevant to contrast agents and imaging devices.

Secondary analysis drew on a systematic review of scientific literature, patent filings, conference proceedings, and public regulatory submissions to characterize technological trajectories in nanoparticle formulation, coil and drive architectures, and reconstruction algorithm advances. Where possible, insights were cross-referenced across multiple sources to validate trends and to identify consensus or divergence among stakeholders. The methodology also incorporated scenario planning to assess the implications of supply chain disruptions, policy shifts, and differential regional regulatory timelines. Throughout, data integrity was maintained via source attribution and methodological transparency, and uncertainty was explicitly acknowledged where evidence was emergent or where competitive information remained confidential.

A strategic conclusion on how coordinated technical, regulatory, and commercial execution can convert magnetic particle imaging's potential into sustained clinical and research impact

Magnetic particle imaging stands at a pivotal juncture where demonstrated technical advantages and growing clinical interest converge with practical challenges related to scaling, regulatory alignment, and supply-chain optimization. The modality's intrinsic specificity to tracer signals and its potential for real-time quantitative imaging provide clear value propositions for targeted clinical applications and for translational research that bridges lab and patient studies. However, the pace and shape of adoption will be determined by how effectively developers address integration with existing workflows, evidence generation for specific indications, and the operational requirements of health systems and research customers.

Forward-looking organizations will be those that integrate tracer and device development, pursue strategic partnerships to de-risk supply and manufacturing, and design regulatory and clinical programs that progressively expand clinical credibility while managing resource commitments. Regional strategies should be informed by local regulatory landscapes and research capabilities, and distribution models must align with the expectations of hospitals and research institutions. With coordinated execution across these domains, magnetic particle imaging can move from promising technological concept to a reliable clinical and research tool that complements existing modalities and opens new avenues for precision diagnostics and therapeutic monitoring.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Particle Imaging Device Market, by Product Type

  • 8.1. Clinical
    • 8.1.1. Organ Specific
    • 8.1.2. Whole Body
  • 8.2. Preclinical
    • 8.2.1. Large Animal
    • 8.2.2. Small Animal

9. Magnetic Particle Imaging Device Market, by Application

  • 9.1. Clinical Diagnosis
    • 9.1.1. Cardiovascular Imaging
    • 9.1.2. Neurological Imaging
  • 9.2. Preclinical Research
    • 9.2.1. Cardiovascular Research
    • 9.2.2. Oncology
      • 9.2.2.1. Metastasis Detection
      • 9.2.2.2. Tumor Imaging

10. Magnetic Particle Imaging Device Market, by Distribution Channel

  • 10.1. Direct Sales
    • 10.1.1. Field Sales
    • 10.1.2. Online Sales
  • 10.2. Distributors
    • 10.2.1. OEM Partners
    • 10.2.2. Third Party

11. Magnetic Particle Imaging Device Market, by End User

  • 11.1. Hospitals
    • 11.1.1. Private Clinics
    • 11.1.2. Public Hospitals
  • 11.2. Research Institutes
    • 11.2.1. Academic
    • 11.2.2. Government

12. Magnetic Particle Imaging Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Magnetic Particle Imaging Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Magnetic Particle Imaging Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Magnetic Particle Imaging Device Market

16. China Magnetic Particle Imaging Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aspect Imaging Ltd.
  • 17.6. Bayer AG
  • 17.7. BMG LABTECH GmbH
  • 17.8. Bruker BioSpin GmbH
  • 17.9. Danfoss A/S
  • 17.10. I'rom Pharmaceutical Co., Ltd.
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Magnetic Insight, Inc.
  • 17.13. MILabs B.V.
  • 17.14. Mitsubishi Electric
  • 17.15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ORGAN SPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY WHOLE BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY LARGE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SMALL ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY NEUROLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY METASTASIS DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY TUMOR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY FIELD SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY OEM PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 224. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 228. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 231. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 266. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 267. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 270. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 273. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 280. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 281. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 283. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 284. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 287. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 288. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 291. GLOBAL MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY PRECLINICAL, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES MAGNETIC PARTICLE IMAGING DEVICE MARK